Sign In
Buy GRWLF
Great-west Lifeco Earnings Calls
| Release date | Jul 28, 2026 |
| EPS estimate | $0.97 |
| EPS actual | $1.00 |
| EPS Surprise | 3.41% |
| Revenue estimate | 1.081B |
| Revenue actual | 1.082B |
| Revenue Surprise | 0.119% |
| Release date | May 06, 2026 |
| EPS estimate | $0.94 |
| EPS actual | $0.99 |
| EPS Surprise | 4.90% |
| Revenue estimate | 1.065B |
| Revenue actual | 1.154B |
| Revenue Surprise | 8.31% |
| Release date | Feb 11, 2026 |
| EPS estimate | $0.94 |
| EPS actual | $0.99 |
| EPS Surprise | 5.10% |
| Revenue estimate | 1.109B |
| Revenue actual | 943.747M |
| Revenue Surprise | -14.87% |
| Release date | Nov 05, 2025 |
| EPS estimate | $0.87 |
| EPS actual | $1.30 |
| EPS Surprise | 48.74% |
| Revenue estimate | 1.022B |
| Revenue actual | 8.52B |
| Revenue Surprise | 733.34% |
Last 4 Quarters for Great-west Lifeco
Below you can see how GRWLF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Nov 05, 2025 |
| Price on release | $15.45 |
| EPS estimate | $0.87 |
| EPS actual | $1.30 |
| EPS surprise | 48.74% |
| Date | Price |
|---|---|
| Oct 30, 2025 | $15.45 |
| Oct 31, 2025 | $15.45 |
| Nov 03, 2025 | $15.45 |
| Nov 04, 2025 | $15.45 |
| Nov 05, 2025 | $15.45 |
| Nov 06, 2025 | $15.45 |
| Nov 07, 2025 | $15.45 |
| Nov 10, 2025 | $15.45 |
| Nov 11, 2025 | $15.40 |
| 4 days before | 0% |
| 4 days after | -0.324% |
| On release day | 0% |
| Change in period | -0.324% |
| Release date | Feb 11, 2026 |
| Price on release | $16.17 |
| EPS estimate | $0.94 |
| EPS actual | $0.99 |
| EPS surprise | 5.10% |
| Date | Price |
|---|---|
| Feb 05, 2026 | $15.45 |
| Feb 06, 2026 | $16.17 |
| Feb 09, 2026 | $16.17 |
| Feb 10, 2026 | $16.17 |
| Feb 11, 2026 | $16.17 |
| Feb 12, 2026 | $16.17 |
| Feb 13, 2026 | $16.17 |
| Feb 17, 2026 | $16.17 |
| Feb 18, 2026 | $16.17 |
| 4 days before | 4.65% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 4.65% |
| Release date | May 06, 2026 |
| Price on release | $15.45 |
| EPS estimate | $0.94 |
| EPS actual | $0.99 |
| EPS surprise | 4.90% |
| Date | Price |
|---|---|
| Apr 30, 2026 | $18.00 |
| May 01, 2026 | $18.00 |
| May 04, 2026 | $18.00 |
| May 05, 2026 | $18.00 |
| May 06, 2026 | $15.45 |
| May 07, 2026 | $18.00 |
| May 08, 2026 | $15.45 |
| May 11, 2026 | $18.00 |
| May 12, 2026 | $18.00 |
| 4 days before | -14.17% |
| 4 days after | 16.50% |
| On release day | 16.50% |
| Change in period | 0% |
| Release date | Jul 28, 2026 |
| Price on release | $15.45 |
| EPS estimate | $0.97 |
| EPS actual | $1.00 |
| EPS surprise | 3.41% |
| Date | Price |
|---|---|
| Jul 22, 2026 | $15.45 |
| Jul 23, 2026 | $15.45 |
| Jul 24, 2026 | $15.45 |
| Jul 27, 2026 | $15.45 |
| Jul 28, 2026 | $15.45 |
| Jul 29, 2026 | $15.45 |
| Jul 30, 2026 | $15.45 |
| Jul 31, 2026 | $15.45 |
| Aug 03, 2026 | $15.45 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
Great-west Lifeco Earnings Call Transcript Summary of Q2 2026
Great-West Lifeco reported a strong Q2 2026 with 15% year-over-year base EPS growth driven by double-digit gains at Empower and Capital & Risk Solutions (CRS). Empower surpassed US$2 trillion in workplace client assets and announced the acquisition of Milliman's Retirement and Benefits Administration business (expected to close later this year), which management expects to be accretive in year one and to strengthen bundled sales capability. Europe delivered mid-single-digit or higher earnings growth, improved capital efficiency (management cites over $3 billion in capital benefits and a 350-basis-point ROE improvement versus 2024), and robust sales including $1.2 billion of UK bulk annuities in the quarter. Canada showed solid retirement and wealth momentum but experienced temporary moderation in long-term disability and individual insurance experience. CRS continues to see strong, but lumpy, global demand for capital solutions, supporting mid-to-high growth. The company remains highly cash generative (free cash flow ~86% of base earnings this quarter), finished Q2 with a LICAT ratio of 128%, HoldCo cash of $2.5 billion and 27% leverage, and is committed to deploying capital through buybacks and M&A — targeting at least the same total capital deployment in 2026 as in 2025.
